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Abstract
Background: Although there is high co-occurrence between ASD and ADHD, the nature of this co-occurrence
remains unclear. Our study aimed to examine the underlying relationship between ASD and ADHD symptoms in a
combined sample of children with a primary clinical diagnosis of ASD or ADHD.
Methods: Participants included children and youth (aged 3-20 years) with a clinical diagnosis of ASD (n = 303) or
ADHD (n = 319) for a total of 622 participants. Parents of these children completed the social communication
questionnaire (SCQ), a measure of autism symptoms, and the strengths and weaknesses of ADHD and normal
behavior (SWAN) questionnaire, a measure of ADHD symptoms. A principal component analysis (PCA) was
performed on combined SCQ and SWAN items, followed by a profile analysis comparing normalized component
scores between diagnostic groups and gender.
Results: PCA revealed a four-component solution (inattention, hyperactivity/impulsivity, social-communication, and
restricted, repetitive, behaviors, and interests (RRBI)), with no overlap between SCQ and SWAN items in the
components. Children with ASD had higher component scores in social-communication and RRBI than children
with ADHD, while there was no difference in inattentive and hyperactive/impulsive scores between diagnostic
groups. Males had higher scores than females in social-communication, RRBI, and hyperactivity/impulsivity
components in each diagnostic group.
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Limitations: We did not formally assess children with ASD for ADHD using our research-criteria for ADHD, and vice
versa. High rates of co-occurring ADHD in ASD, for example, may have inflated component scores in inattention
and hyperactivity/impulsivity. A disadvantage with using single informant-based reports (i.e., parent-rated
questionnaires) is that ASD and ADHD symptoms may be difficult to distinguish by parents, and may be interpreted
differently between parents and clinicians.
Conclusions: ASD and ADHD items loaded on separate components in our sample, suggesting that the
measurement structure cannot explain the covariation between the two disorders in clinical samples. High levels of
inattention and hyperactivity/impulsivity were seen in both ASD and ADHD in our clinical sample. This supports the
need for a dimensional framework that examines neurodevelopmental domains across traditional diagnostic
boundaries. Females also had lower component scores across social-communication, RRBI, and hyperactivity/
impulsivity than males, suggesting that there may be gender-specific phenotypes related to the two conditions.
Keywords: Co-morbidity, ASD, ADHD, Symptoms, Gender, Principle component analysis
Background
Autism spectrum disorder (ASD) and attention-deficit/
hyperactivity disorder (ADHD) are both relatively com-
mon neurodevelopmental conditions [1, 2]. Despite
there being no overlap in criteria between the two disor-
ders as described in the DSM-5 [3], empirical studies
have demonstrated a high level of co-occurrence be-
tween ASD and ADHD in both clinical and population
samples [4]. In population-based samples, 22% (95%
confidence interval, 95% CI 17-26%) of people with ASD
are clinically diagnosed with ADHD, with even higher
rates in clinical samples (34%, 95% CI 29-39%) [5]. In
children and adolescents with ADHD, 21% (95% CI 18-
24%) reach the diagnostic threshold for ASD [6]. A bet-
ter understanding of the relationship between ASD and
ADHD is required in order to understand the mechan-
ism of the co-occurrence, minimize diagnostic error, and
personalize treatment opportunities.
One possible explanation for the co-occurrence between
ASD and ADHD is that they share common etiologies [7].
Evidence for shared genetic liability is supported by family
and twin studies [8, 9], alongside general population stud-
ies [10, 11]. Twin studies have also examined the correla-
tions between specific ASD and ADHD domains, and
found a high genetic correlation between restricted repeti-
tive behaviors and interests (RRBI) and domains of in-
attention and hyperactivity/impulsivity [9, 12, 13], and
between social-communication and hyperactivity/impul-
sivity [10].
Despite evidence of possible shared etiologies between
ASD and ADHD, our understanding of the underlying
relationship of combined ASD and ADHD behavior
symptoms is limited. Delineating the relationship be-
tween core domains of different neurodevelopmental
conditions can help us better understand the nature of
their co-occurrence. If the core domains underlying
ASD and ADHD overlap, this could suggest either that
(1) the two disorders share a common latent phenotypic
construct, or (2) there is substantial measurement error
or reporting bias.
A common latent phenotypic construct is found when
item responses on a questionnaire are so highly corre-
lated that they represent a common underlying domain.
For example, if certain ASD and ADHD questionnaire
items are highly correlated, they may load together in a
principal component analysis and reveal a common
underlying ASD/ADHD domain. A common ASD/
ADHD domain might mean that certain ASD and
ADHD traits are actually shared between the two disor-
ders. Reporting bias can be observed when the same in-
formant reports on both disorders, i.e., high scores on
one disorder may bias an informant to rate an individual
high (or low) on another disorder. A common latent
phenotypic construct and measurement error may sug-
gest an artificial co-occurrence between the two disor-
ders. In contrast, if ASD and ADHD are associated with
independent latent phenotypic constructs, this could
suggest a “true” comorbidity in which measurement
structure has no influence on the covariation between
the two disorders.
Factor analysis techniques are data reduction techniques
that decompose symptoms into their underlying con-
structs or dimensions. One commonly used factor analysis
technique is principal component analysis (PCA). The
underlying dimensions that are extracted in PCA are re-
ferred to as components [14]. It is well established from
factor analysis studies that ADHD is composed of separate
inattentive and hyperactivity/impulsivity domains [15, 16].
Likewise, recent factor analysis studies of ASD reveal sep-
arate social/communicative and RRBI domains [17, 18].
To our knowledge, only four studies to date have exam-
ined the latent constructs of combined ASD and ADHD
symptoms in the same sample. One study used a clinical
sample of children with ADHD [19], one used a clinical
sample of children with ASD [20], and two used samples
of children from the general population [12, 21]. Three
Krakowski et al. Molecular Autism           (2020) 11:28 Page 2 of 13
studies found that ASD and ADHD symptoms mapped
onto separate factors/components [12, 20, 21] and only
one study [19] supported an overlapping three-factor solu-
tion composed of a social factor, an inattentiveness factor,
and a third factor in which rigidity symptoms and
hyperactive-impulsive symptoms grouped together. Given
the paucity of studies on the topic and the heterogeneity
in samples and methods, it is still unclear whether ASD
and ADHD domains load together or onto separate do-
mains. None of the prior studies was done on a combined
sample of ASD and ADHD participants, which would pro-
vide a more robust test of the possibility that a shared la-
tent construct underlies the co-occurrence of ASD and
ADHD. No study that we are aware of has also looked into
the variation in factor/component scores across the two
diagnostic groups. Furthermore, gender-specific pheno-
types of ASD and ADHD have been proposed [22, 23],
and yet only one study that we are aware of has looked at
variation in factor/component scores across gender [19].
The aims of our study were (i) to determine the princi-
pal components of combined ASD and ADHD symp-
toms in a clinical sample of children with a primary
diagnosis of ASD or ADHD and (ii) to investigate
whether there are differences in component scores
across diagnosis and gender.
Methods
Participants
Children and youth (aged 3-20 years) with a clinical
diagnosis of ASD or ADHD were recruited via the Prov-
ince of Ontario Neurodevelopmental Disorders (POND)
Network, Canada. Participants were included if they had
a primary clinical diagnosis of ADHD or ASD, and par-
ticipants and their caregivers had sufficient English com-
prehension to complete required testing. Participants in
the current study were enrolled between 2012-2017. Eth-
ics approval was received from each participating institu-
tion’s ethics review board.
Children with a primary diagnosis of ASD that were
enrolled in the study had previously received a clinical
diagnosis of autism, Asperger’s disorder/syndrome, or
PDD-NOS by either a psychiatrist, clinical psychologist,
developmental pediatrician, pediatrician, family phys-
ician or pediatric neurologist. Likewise, children with a
primary clinical diagnosis of ADHD had previously re-
ceived the diagnosis by either a psychiatrist, clinical
psychologist, developmental pediatrician, pediatrician,
family physician, or pediatric neurologist. Upon study
enrollment, previous clinical diagnoses of ASD were
confirmed using the Autism Diagnostic Observation
Schedule, 2nd edition (ADOS-2) [24, 25] and Autism
Diagnostic Interview-Revised (ADI-R) [26]. Previous
clinical diagnoses of ADHD were confirmed using the
parent interview for child symptoms (PICS) for ADHD
[27]. The PICS is a semi-structured interview developed
particularly for the diagnosis of disruptive behavior dis-
orders, including ADHD. All diagnoses were made based
on criteria in the DSM-IV-TR [28] or DSM-5 [3] de-
pending on the time of diagnosis.
A total of 439 ASD participants and 425 ADHD partici-
pants had both the ASD symptom (SCQ) and the ADHD
symptom (SWAN) measures completed by their care-
givers. Those with any missing data on either the SWAN
or SCQ were excluded (ASD: n = 101; ADHD: n = 106).
We also excluded non-verbal children (n = 35) as these
children by necessity had questions 2-7 incomplete on the
SCQ. This resulted in a complete dataset of n = 303 in the
ASD group and n = 319 in the ADHD group.
The number of children who were listed as having a
co-occurring prior clinical ASD or ADHD diagnosis by
their caregivers was also identified. Fifty-five children
with a primary diagnosis of ASD were listed as having a
co-occurring clinical ADHD diagnosis and 4 children
with a primary diagnosis of ADHD were listed as having
a co-occurring clinical ASD diagnosis. In cases of such
co-occurring diagnoses, the diagnosis the participant
had received first is referred to as the “primary diagno-
sis.” In the PCA analysis and subsequent profile analysis
children remained grouped solely by their primary
diagnosis.
Gender information was obtained from caregivers
upon study enrollment. The two options provided on
the patient enrollment form under “gender” were “male”
and “female.” This information was used for subsequent
profile analysis.
Measures
ASD symptoms were assessed using the social commu-
nication questionnaire (SCQ) [29], a 40-item question-
naire that asks parents or caregivers to indicate the
presence or absence of certain behaviors to help screen
for autism. A score of 1 indicates the presence of an
atypical behavior and a score of 0 indicates the atypical
behavior is absent. The scale has good reliability and val-
idity [30]. A score of 15 and above suggests the need for
a formal assessment for ASD [30]. We used this score
cutoff to define “caseness” in our descriptive data. Since
item 1 is a language screening question it is not included
in calculating the total of autistic symptoms.
ADHD symptoms were assessed using the strengths
and weaknesses of ADHD symptoms and normal behav-
ior rating scale (SWAN) [31], an 18-item questionnaire
based on DSM-IV ADHD criteria. The SWAN has good
reliability and validity [32, 33]. Caregivers, or other in-
formants, rate each item on a seven-point scale with
average behavior in the middle and positive and negative
extremes of the behavior scored on either end. If a par-
ticipant has six or more items on the two most negative
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extremes of behavior (“far below” or “below”) for the in-
attentive or the hyperactive/impulsive domain, they are
determined to score within the ADHD clinical range,
which we refer to as ADHD “caseness.” SWAN items
were re-coded on a seven-point Likert scale from 0 to 6.
For consistency in directionality with the SCQ, all items
were reverse coded so that negative extremes of behavior
received the highest score.
IQ was assessed with age-appropriate Weschler or
Stanford-Binet scales. When more than one IQ score
was available for a participant, the most recent IQ as-
sessment was used. Adaptive functioning was assessed
with the adaptive behavior assessment system (ABAS)
first or second edition [34, 35]. The ABAS manual docu-
ments good validity and reliability [34]. Composite
scores were determined for the conceptual, social and
practical domains.
Analysis
Agreement between questionnaire caseness and clinical
diagnosis
The level of agreement beyond chance between ASD or
ADHD caseness and having a clinical diagnosis of ASD
or ADHD as noted by the parent or caregiver was calcu-
lated for children with a primary diagnosis of ADHD
and ASD, respectively, using Cohen’s kappa.
Preliminary analysis
To remove redundant items, kappa was calculated be-
tween pairs of SCQ items (SCQ2-SCQ40) and between
pairs of SWAN items (SWAN1-SWAN18). A kappa
above 0.80 is considered “strong agreement” [36] and
this value was used to remove redundant items. Kappa
scores between SCQ items 24 and 25 indicated “strong
agreement” (> 0.80), so item 25 was removed from the
analysis. No items on the SWAN had such high kappa
scores.
The correlation between SCQ and SWAN variables
was examined using a correlation matrix. Tetrachoric
and Pearson correlations were used to examine correla-
tions between dichotomous (SCQ) and continuous
(SWAN) variables, respectively. Biserial correlations
were used to examine correlations between SCQ and
SWAN items.
The following sets of items had very high correlations
(> 0.80): SCQ 3 and 7; SCQ 28 and 30; SCQ 35 and 39;
and SWAN 10 and 11. In all cases, the second question
in the pair was excluded from further analysis to reduce
multicollinearity (SCQ7, SCQ30, SCQ39, and SWAN11).
SCQ9 and SCQ23 were also removed from the com-
bined SCQ-SWAN analysis as they had a low Kaiser-
Meyer-Olkin (KMO) (< 0.85) [37]. The KMO helps de-
termine whether there is a strong correlation between
variables, and therefore helps determine whether they
are suitable for PCA. Low KMO values were not found
for any SWAN items.
Principal components analysis
We chose to use a PCA instead of an exploratory factor
analysis as it is a simpler data reduction technique to
use as a first step in understanding underlying ASD and
ADHD dimensions. All principal component analyses
were performed using R v3.5.1. Component scores were
generated in R.
We performed a PCA on SCQ items combined with
SWAN items in the combined clinical sample of chil-
dren with ASD and ADHD. The KMO = 0.92 was “su-
perb” [37], indicating sampling size and data adequacy.
All KMO values for individual items were > 0.86. Bar-
lett’s test of sphericity was significant, χ (1225) = 25,880,
p < 0.01, indicating that the data were suitable to be
used in a PCA.
For all PCAs, an oblique rotation (oblimin) was used to
permit components to correlate with one another. To se-
lect the most appropriate principal components solution
for each analysis, we considered the following criteria: (1)
eigenvalues, (2) scree plots, (3) percentage of variance ex-
plained, (4) minimum number of item cross-loadings, and
(5) clinical interpretability of the components.
After a component solution was derived, correlations
between components were examined. We defined correl-
ation coefficients of 0.10-0.29 as small, 0.30-0.49 as
medium and ≥ 0.50 as large [38].
Comparison of ASD and ADHD population with sample
constructs
Before we could use the component scores of our com-
bined ASD-ADHD sample PCA in a profile analysis, we
needed to be confident that the components of our ASD
sample and ADHD sample were similar. A PCA of the
SCQ and SWAN items was performed separately in the
ASD and ADHD samples. The PCAs of the ASD and
ADHD samples were then compared on the number of
components, the composition of the components, variance
explained, and correlations between the components.
When ASD and ADHD PCAs were performed separ-
ately they revealed similar components (Supplemental
Tables 3 and 4). There was no overlap between SCQ
and SWAN items in the ASD group except for the load-
ing of SCQ16, SCQ2, and SCQ17 in the “hyperactivity/
impulsivity” component. There was no overlap between
SCQ and SWAN items in the ADHD group except for
the loading of SCQ4 in the “hyperactivity/impulsivity”
component.
Component scores
Component scores for each participant in the combined
ASD-ADHD analysis were generated using tenBerge
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method in the psych library to preserve the oblique solu-
tion. Component scores were normalized to vary be-
tween 0 and 1 across groups using observed min/max to
permit comparisons between groups and components in
the profile analysis.
Profile analysis with component scores
Profile analysis was conducted in SPSS version 22 [39]
using the normalized (0-1) component scores generated
in the PCA. Profile analysis aims to test whether groups
have different profiles on certain measures and is con-
sidered to be a special application of the multivariate
analysis of variance (MANOVA) [40]. We explored the
profiles for the symptom components between clinical
diagnoses (ASD, ADHD) and between genders (male, fe-
male). We considered whether the overall levels were
equal, i.e., whether across the groups (diagnosis, gender)
one diagnosis or gender had a higher total score than
another diagnosis or gender when scores on all four
symptom components were combined. We also consid-
ered whether the lines were parallel, i.e., whether across
the groups (diagnosis, gender) the different diagnoses
and genders were similar in profile of the four symptom
components but possibly different in the level of each
symptom component. We then assessed the flatness of
the four symptom components, i.e., whether there was
similarity in the amount of each of the four symptom
components within the different groups (diagnosis, gen-
der). The four-component scores were the within-
participant contrast and both diagnosis (ASD, ADHD)
and gender (male, female) were between-participants
contrasts. Where profile analysis identified significant
differences, individual group-wise (diagnosis, gender,
and the interaction of diagnosis and gender) ANOVAs
with Bonferroni correction for multiple testing (α =
0.05/4 = 0.0125) were used to determine specifically
which groups were different for each symptom
component.
Results
Missing vs. complete datasets
ASD participants from the complete dataset did not dif-
fer from those with missing data in terms of age, gender,
SCQ score, SWAN inattention score, and SWAN hyper-
activity/impulsivity score (Supplemental Table 1). There
was a significant difference on IQ and ABAS scores with
those with complete data having significantly higher IQ
(p = 0.02) and ABAS composite scores for all domains
(p < 0.01).
ADHD participants from the complete dataset did not
differ from those with missing data in terms of gender,
SCQ score, SWAN inattention score, SWAN hyperactiv-
ity/impulsivity score, IQ, and ABAS scores (Supplemen-
tal Table 2). ADHD children with complete data were
significantly older than ADHD children with missing
data (p = 0.03).
ASD and ADHD samples
Descriptive data of the complete study sample is shown
in Table 1.
Agreement between questionnaire caseness and clinical
diagnosis
While 53.14% of children with a primary diagnosis of
ASD met the threshold for ADHD caseness on the
SWAN, only 18.97% were listed as having a known sec-
ondary ADHD diagnosis. While 13.48% of children with
a primary diagnosis of ADHD met the threshold for
ASD caseness on the SCQ, only 1.36% were listed as
having a known secondary ASD diagnosis. The level of
agreement between ADHD caseness and having a co-
occurring ADHD diagnosis by caregiver report was
“slight” [36] (κ = 0.12) for children with a primary diag-
nosis of ASD. The level of agreement between ASD
caseness and having a co-occurring ASD diagnosis was
also “slight” [36] (κ = 0.07) for children with a primary
diagnosis of ADHD. Most cases of ADHD or ASD iden-
tified by questionnaires were not reflected in co-
occurring clinical diagnoses.
Combined ASD-ADHD sample principal component
analysis
In the combined sample of clinically diagnosed ASD and
ADHD participants, a PCA was conducted on the 34
SCQ and 17 SWAN items with oblique rotation on the
622 children with a primary clinical diagnosis of ASD or
ADHD. The scree plot showed an inflection occurring
after 4 points, which explained 55% of the variance. All
4 components had an eigenvalue greater than 1. A four-
component solution was chosen based on the scree plot,
eigenvalues, proportion of explained variance, and clin-
ical interpretability of the components.
Item loadings are shown in Table 2. The first compo-
nent consisted mainly of social and communication
items from the SCQ and was labeled the “social-commu-
nication” component. The second component consisted
mainly of RRBI items from the SCQ and was labeled the
“RRBI” component. The third component consisted of
inattentive items from the SWAN and was labeled the
“inattentive” component. Finally, the fourth component
consisted of hyperactivity/impulsivity items from the
SWAN and was labeled the “hyperactivity/impulsivity”
component. There was no overlap between SCQ and
SWAN items in any of the components.
Component correlations
The “social-communication” component had a moderate
correlation with the “RRBI” component (0.41), and low
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correlations with the “inattentive” and “hyperactivity/im-
pulsivity” components, (0.11 and 0.10, respectively). The
“RRBI” component had a low correlation with the “hyper-
activity-impulsivity” component (0.17) and minimal cor-
relation with the “inattentive” component (< 0.01). The
“hyperactivity-impulsivity” component showed a moderate
correlation with the “inattentive” component (0.34).
Component scores
The sum of the normalized component scores for each
domain for each participant is shown in Fig. 1. Each
child could have a score on the component domain that
ranged from 0 to 1.0 or a total score ranging from 0 to
4.0. Figure 1 shows that the component scores generally
line up with the clinical diagnosis. However, there seems
to be a sub-group of ADHD children with high social-
communication component scores. A total of 11.91% of
ADHD children had normalized social-communication
component scores > 0.5 in this domain. In comparison,
42.24% of ASD children had a normalized component
score of > 0.5 in this domain.
Profile analysis
Overall, mean levels were not equal by diagnosis (F
(1620) = 174.26, p < 0.001) or by gender (F (1620) =
613.63, p < 0.001), and there was no interaction between
diagnosis and gender (F (1618) = 0.91, p = 0.34) with regard
to overall levels of all four combined components. The tests
of levels indicate that across all four components, there was
a higher overall level of total scores in children in ASD than
ADHD and in males than females. The test of parallel lines
was significant for symptom components by diagnosis (F
(3618) = 139.93, p < 0.001) and for symptom components
by gender (F (3616) = 2.64, p = 0.05), but not for the inter-
action between symptom components by diagnosis by gen-
der (F (3616) = 0.07, p = 0.97). The test of parallel lines
indicates that the groups are not parallel by diagnosis,
meaning that ADHD is not simply a milder version of ASD
with lower levels of all symptom domains. Similarly, gen-
ders are not parallel, indicating that females are not scoring
equally lower in all domains compared to males. The test
of flatness was significant for diagnosis (F (31854) = 88.72,
p < 0.001), but not for gender (F (31854) = 2.06, p = 0.10)
and there was no interaction between diagnosis and
gender (F (31854) = 0.06, p = 0.98). The test of flat-
ness indicates that the diagnostic groups have signifi-
cantly different amounts of one or more symptom
components than that of other symptom components.
The non-significant effect of gender and the inter-
action term indicates that it is the diagnosis, more so
than gender, that drives the differences in the individ-
ual levels of the four symptom components.
Table 1 Descriptive data of study sample
ASD (n = 303) ADHD (n = 319) p value Cohen’s
dMean (SD) Mean (SD)
Age (years) 11.22 (3.43) 10.08 (2.74) < 0.001** 0.37
IQa 87.49 (24.63) 97.50 (15.91) < 0.001** 0.48
ABAS composite scoresb
Conceptual 71.07 (15.36) 81.38 (14.04) < 0.001 ** 0.70
Social 70.96 (12.43) 85.68 (16.52) < 0.001 ** 1.00
Practical 64.23 (18.35) 79.49 (17.19) < 0.001 ** 0.86
SCQ score 19.96 (7.86) 7.76 (5.94) < 0.001 ** 1.75
SWAN INA score 4.72 (2.94) 5.40 (2.88) < 0.01 ** 0.23
SWAN IMP/HYP score 3.68 (2.96) 3.49 (3.10) 0.43 0.06
n (%) n (%) p value
Males 242 (79.87%) 253 (79.31%) 0.92
Clinical co-occurring ASDc - 4 (1.36%) -
Clinical co-occurring ADHDd 55 (18.97%) - -
ASD caseness 221 (72.94%) 43 (13.48%) < 0.001**
ADHD caseness 161 (53.14%) 200 (62.70%) 0.02*
ADHD attention-deficit/hyperactivity disorder, ASD autism spectrum disorder, ABAS adaptive behavior assessment system, SCQ social communication
questionnaire, SWAN strengths and weaknesses of ADHD symptoms and normal behavior questionnaire, INA inattention, HYP/IMP hyperactivity/impulsivity
a30 ASD participants were missing IQ information and 193 ADHD participants were missing IQ information
b24 ASD participants were missing ABAS information and 131 ADHD participants were missing ABAS information
c13 ASD participants were missing co-occurring mental health condition information
d25 ADHD participants were missing co-occurring mental health condition information
*p < 0.05
**p < 0.01
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SCQ 28—show things to engage interest (4/5) SOC 0.91
SCQ 20—talk to be friendly (4/5) COM 0.80
SCQ 27—reciprocates smiles (4/5) SOC 0.80
SCQ 29—shares things (4/5) SOC 0.79
SCQ 24—nod head (4/5) COM 0.78
SCQ 35—pretend play (4/5) COM 0.77
SCQ 22—points to show things (4/5) COM 0.77
SCQ 31—comforts others (4/5) SOC 0.77
SCQ 32—use gestures with sounds or words (4/5) SOC 0.77
SCQ 2—has to and fro conversation COM 0.76
SCQ 33—normal range of facial expressions (4/5) SOC 0.75
SCQ 36—interested in other children (4/5) SOC 0.75
SCQ 37—positive response to other children (4/5) SOC 0.72
SCQ 34—joins in social games (4/5) COM 0.71
SCQ 21—spontaneously copies others actions (4/5) COM 0.70
SCQ 40—plays cooperatively with others (4/5) SOC 0.67 0.32
SCQ 26—looks at faces (4/5) SOC 0.59
SCQ 38—pays attention without name being called (4/5) SOC 0.55 0.36
SCQ 19—has friends SOC 0.53
SCQ 11—odd interests RRB 0.79
SCQ 13—intense interests RRB 0.75
SCQ 18—has to carry around specific object RRB 0.74
SCQ 12—interested in parts of objects RRB 0.73
SCQ 14—unusual sensory interests RRB 0.70
SCQ 6—makes up words COM 0.70
SCQ 3—uses odd phrases RRB 0.68
SCQ 15—odd movements RRB 0.65
SCQ 10—uses other’s hand as tool SOC 0.64
SCQ 16—repetitive complicated movements RRB 0.64
SCQ 8—has rituals RRB 0.63
SCQ 5—mixes up pronouns COM 0.62
SCQ 4—asks socially inappropriate questions SOC 0.60
SCQ 17—engages in self-harm RRB 0.44
SWAN 14—control constant activity HYP/IMP 0.82
SWAN 13—plays quietly HYP/IMP 0.79
SWAN 17—awaits turn HYP/IMP 0.79
SWAN 15—controls excess talking HYP/IMP 0.77
SWAN 16—controls blurting out answering HYP/IMP 0.77
SWAN 10—sits still HYP/IMP 0.67
SWAN 12—modulates motor activity HYP/IMP 0.65
SWAN 5—organizes tasks INA 0.85
SWAN 7—loses things INA 0.81
SWAN 4—follows through on instructions INA 0.73
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A profile plot comparing component scores between
diagnostic groups and genders across the components is
shown in Fig. 2. Subsequent ANOVAs revealed that, while
there was a significant difference in social-communication
(F (1618) = 75.48, p < 0.01) and RRBI (F (1618) = 258.96, p
< 0.01) component scores between the two diagnostic
groups, there was no significant difference in inattentive (F
(1618) = 5.67, p = 0.02) or hyperactive/impulsive (F (1618)
= 0.31, p = 0.58) component scores between diagnostic
groups. Males had higher social-communication (F (1618)
= 9.10, p < 0.01), hyperactivity/impulsivity (F (1618) = 9.00,
p < 0.01), and RRBI (F (1618) = 10.60, p < 0.01) component
scores than females within each diagnostic group. There
was no significant difference between males and females in
inattentive (F (1618) = 0.93, p = 0.34) component scores.
Discussion
High rates of co-occurrence between ASD and ADHD
have been reported [5, 6]. To date, few studies have ex-
amined the underlying relationship between the core do-
mains of combined ASD and ADHD symptoms. Our
PCA revealed a four-component solution with no over-
lap between SCQ and SWAN items in the components.
Children with ASD had higher scores in social-
communication and RRBI components than children
with ADHD, while there was no difference in inattentive











SWAN 9—forgetfulness INA 0.69
SWAN 6—engages in tasks requiring mental effort INA 0.69
SWAN 1—attention to detail INA 0.69
SWAN 2—sustains attention INA 0.61
SWAN 3—listens when spoken to INA 0.46 0.35
SWAN 8—easily distracted INA 0.38
Component loadings above 0.3 are shown
ADHD attention-deficit/hyperactivity disorder, ASD autism spectrum disorder, SCQ social communication questionnaire, SWAN strengths and weaknesses of ADHD
symptoms and normal behavior questionnaire, RRBI restricted repetitive behaviors and interests, INA inattention, HYP/IMP hyperactivity/impulsivity
Fig. 1 Normalized component scores, stacked by individual. Normalized component scores are summed for each individual in this stacked graph.
Each child can have a score between 0 and 1 for each of the four components. Data are sorted from largest to smallest based on the sum of the
social-communication and RRBI symptom domain component scores within each diagnosis
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and hyperactive/impulsive component scores between
diagnostic groups. Males had higher component scores
than females in social-communication, RRBI, and hyper-
activity/impulsivity within each diagnostic category.
In our sample, while 53.14% of children with a primary
diagnosis of ASD met the threshold for ADHD caseness
on the SWAN, only 18.97% were listed as having a
known co-occurring ADHD diagnosis. While 13.48% of
children with a primary diagnosis of ADHD met the
threshold for ASD caseness on the SCQ, only 1.36%
were listed as having a known co-occurring ASD diagno-
sis. This suggests that co-occurring ASD in children with
ADHD (and vice versa) may be under-identified and
highlights the importance of assessing for co-occurring
symptomatology in this population. Since the SCQ and
SWAN were filled out by caregivers it is also important
to consider that rates of ASD and ADHD caseness on
the SCQ and SWAN, respectively, may have been over-
represented in our sample.
Even though ASD has an earlier age of onset than
ADHD, studies have shown that many children with
ASD are first diagnosed with having ADHD, subse-
quently leading to a delay in a diagnosis of ASD [41, 42].
This can have important consequences for access to ser-
vices. Clinically, ADHD symptoms can overshadow
those of ASD or clinicians may “expect” to see a more
common disorder such as ADHD and might not carry
out a careful assessment of other diagnoses. While Na-
tional Institute for Health Care and Excellence ADHD
guidelines caution that there are high levels of ADHD in
children with ASD [43], the American Academy of Child
and Adolescent Psychiatry ADHD practice parameter
guidelines do not mention ASD [44] in the differential
diagnosis. Based on our findings, co-occurring ASD in
children with ADHD may be under-identified and we
suggest that the importance of assessing for co-
occurring ASD symptomatology in the ADHD popula-
tion be considered in future guideline revisions.
When conducting a PCA on combined ASD and
ADHD symptom measures in a sample of children with
a primary diagnosis of ASD or ADHD, we found no
overlap between ASD and ADHD items comprising the
components. SCQ items loaded onto two ASD compo-
nents (social-communication and RRBI) and SWAN
items loaded onto two ADHD components (inattention
and hyperactivity/impulsivity). Therefore, the explan-
ation for the co-occurrence between the two disorders
cannot simply be due to an overlap in their core do-
mains. Also, there were low correlations between do-
mains, so it is not a matter of scoring high on all
components, which might reflect reporting bias. This
suggests that the measurement structure cannot explain
the covariation between the two disorders in clinical
samples. We cannot assess “true comorbidity” based on
the present findings since parent report bias has not
been addressed in this study.
Our findings are in contrast to the study by Martin
et al. [19] which found overlap between hyperactivity/
impulsivity and RRBI domains in a sample of children
with ADHD. Although we used PCA instead of
Fig. 2 Profile plot with diagnosis by gender. There was no difference in inattentive and hyperactive/impulsive component scores between the
two diagnostic groups (p < 0.01). Males had higher social-communication, hyperactivity/impulsivity, and RRBI component scores regardless of
diagnosis (p < 0.01). Two asterisks (**) indicate a diagnosis effect. A degree sign (°) indicates a gender effect
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exploratory factor analysis, both our study and the
Martin et al. [19] study used an oblique rotation (allow-
ing components to correlate) and the SCQ as a measure
of ASD symptoms. Interestingly, in their sample of
ADHD children, Martin et al. [19] reported finding an-
other factor solution in which ASD and ADHD did not
overlap, and consisted of three ASD factors and two
ADHD factors. Such a finding is in line with the results
of our study, which also found that ASD and ADHD
items loaded independently onto separate components.
Of note, Martin et al. [19] chose the competing three-
factor solution composed of a social (ASD) factor, an in-
attentive (ADHD) factor, and a factor in which RRBI
(ASD) and hyperactivity/impulsivity (ADHD) traits
grouped together because it had a lower range of factor
inter-correlations and greater parsimony. It is also im-
portant to consider that our sample had a relatively
higher IQ score than Martin et al.’s. Given that IQ is
negatively correlated with ASD and ADHD symptoms
[45, 46], it is unclear how much IQ may have explained
the difference in findings between the two studies.
Interestingly, our PCA of ASD children (Supplemental
Table 3) revealed cross-loading of a few ASD items onto
the ADHD hyperactivity/impulsivity component, and
our PCA of ADHD children (Supplemental Table 4) re-
vealed cross-loading of one ASD item onto the ADHD
hyperactivity/impulsivity component. Since these items
suggest potential misattribution of ASD traits for those
of ADHD, and vice versa, we re-ran the PCA without
these items, as a sensitivity analysis, to determine
whether it resulted in a model with more variance ex-
plained. This PCA produced a similar model, with four
components with similar variance explained (58 % vs.
55% in the original model).
In our study, 11.91% of ADHD children had normal-
ized component scores > 0.5 in the social-
communication domain. This agrees with latent class
analysis studies that have shown considerable heterogen-
eity when looking at the intersection of ASD and ADHD
symptoms across subgroups [47–49]. Given the hetero-
geneity seen in ADHD, it is possible that there is a sub-
group of ADHD children with significant and impairing
problems in social-communication without accompany-
ing RRBI, similar to the DSM-5 social (pragmatic) com-
munication disorder or the so-called broader autism
phenotype [50, 51] seen in first degree relatives of pro-
bands with ASD. Further study of this group might
prove revealing in terms of biomarker and genetic vari-
ant overlap with ASD.
Using profile analysis, our study showed that there was
no difference in inattentive and hyperactivity component
scores between ASD and ADHD groups. This suggests a
possible mechanism for the increasing literature showing
an overlap between ASD and ADHD on genetic and
neuroimaging levels [7, 52]. This overlap might be
accounted for by similar levels of inattentive and hyper-
active/impulsive phenotypes in the two groups instead of
variation in social-communication and RRBI.
By finding high levels of inattention and hyperactivity/
impulsivity in ASD and ADHD, our study supports the
need for a dimensional framework that examines neuro-
developmental domains (social-communication, RRBI,
inattention, and hyperactivity/impulsivity) across trad-
itional ASD and ADHD diagnostic boundaries. This no-
tion is also supported by recent neuroimaging studies in
children with ASD and ADHD [53–55]. In the POND
cohort, Baribeau et al. [55] found that structural neuro-
imaging correlates of social deficits were similar across
ASD and ADHD, and Kushki et al. [54] found that clus-
ters identified among children with ASD, ADHD, and
OCD based on cortical thickness and behavioral pheno-
typic features did not map well onto traditional diagnos-
tic categories. In a separate cohort, Aoki et al. [53]
further showed that ASD severity across both children
with ASD or ADHD was associated with specific white
matter organization indices and that a dimensional ap-
proach provided a more comprehensive picture of white
matter associations than a categorical approach. Our
study adds to the literature by showing that ASD and
ADHD groups differ on component scores in social-
communication and RRBI domains, suggesting that
some domains may be relatively more disorder-specific
and may be useful in identifying certain subgroups in
ASD and ADHD.
We also found that females had lower component
scores across social-communication, RRBI, and hyper-
activity/impulsivity domains. This suggests that there
may be gender-related phenotypes associated with the
two neurodevelopmental disorders. A “female pheno-
type” of ASD has been proposed in the literature [22],
one aspect being that females generally show less RRBIs
than males [56]. However, it has also been argued that
“gold standard” diagnostic instruments are potentially
male-biased and RRBIs that are more prevalent in fe-
males may be harder to capture using these instruments.
Females may also show different forms of social-
communication difficulties than males, being better able
to express themselves socially but having similar levels
of social difficulties as males [56, 57]. This suggests that
females may tend to have a better ability to “camouflage”
or compensate their autism, for example, by imitating
social scripts [58, 59]. In terms of ADHD, females tend
to have less hyperactive symptoms and externalizing be-
haviors than males [23], which agrees with our findings
that females have lower component scores in the hyper-
activity/impulsivity domain than males.
Interestingly, when looking at factor scores across gen-
ders in their combined ASD-ADHD symptom analysis,
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Martin et al. [19] did not find any differences in “social,”
“rigidity-hyperactivity,” or “inattentiveness” domains be-
tween males and females. Compared to this study, our
participants had higher IQ; therefore, it is possible that
females in this group were better able to “camouflage”
or compensate their ASD characteristics, hence such
presentations were less noticeable and therefore scored
lower by caregivers. ADHD characteristics in females
with higher IQ may also be less noticeable due to com-
pensation of the child or recognition biases of caregivers,
especially if there are fewer concerns about their school
performance. These influences may have widened the
difference in social-communication, RRBI, and hyper-
activity/impulsivity component scores between males
and females in our sample.
The strengths of our study include the large sample
size of participants with ASD (n = 303) and ADHD (n =
319). The primary clinical diagnoses of all the study par-
ticipants were also confirmed with valid and reliable
measures: the PICS for ADHD [27] and the ADOS-2
[24] and ADI-R [26] for ASD. Our study also used a
combined sample of children with a primary diagnosis
of ASD or ADHD which provides a larger sample size
and a more robust test of the underlying relationship be-
tween the core domains of ASD and ADHD symptoms
than a sample of children with ASD or ADHD alone.
Limitations
Our study had several limitations. First, we did not per-
form the ASD diagnostic interviews on the clinically re-
ferred ADHD participants, and we did not perform an
ADHD diagnostic interview on the clinically referred
ASD participants. It is therefore unclear which ASD and
ADHD participants had a co-occurring ADHD or ASD
diagnosis, respectively, defined using the same research
criteria. Such information would be helpful as an in-
creased number of ASD participants with co-occurring
ADHD might increase levels of inattention and hyper-
activity/impulsivity and an increased number of ADHD
participants with co-occurring ASD might increase levels
of social-communication and RRBI symptoms. Future
studies should consider comparing ASD, ADHD, and co-
occurring ASD + ADHD groups separately when examin-
ing neurodevelopmental domain scores. Although our
study did collect information from caregivers about co-
occurring diagnoses, including ASD and ADHD, it is un-
clear if this information is sufficiently valid, and many par-
ticipants may not have been assessed for co-occurring
diagnoses or may have been misdiagnosed. It is important
for future studies to formally assess for co-occurring diag-
noses using validated instruments across all participants.
Second, we used parent-rated questionnaires. A disad-
vantage with using single informant-based reports is that
some ASD and ADHD symptoms may be difficult to
distinguish by parents, and may be interpreted differ-
ently between parents and clinicians [60].
Third, we excluded participants with missing data on
the rating scales (which included non-verbal or minim-
ally verbal participants). Children with incomplete rating
scales had significantly lower IQ and ABAS scores,
which likely resulted in a biased sample of participants
for our PCA.
Finally, we combined two different rating scales
with continuous (SWAN) and dichotomous (SCQ)
variables in the PCA. It is therefore unclear to what
extent our findings might be influenced by items
from the same questionnaire grouping together as a
result of being in the same measurement scale. It
would be interesting to conduct a PCA on ASD and
ADHD items from the same questionnaire, such as
the child behavior checklist (CBCL); however, such
questionnaires are typically based on broad DSM-
based criteria and as such do not adequately capture
ASD symptomatology.
Conclusions
ASD and ADHD items loaded on separate components
in our sample, suggesting that the measurement struc-
ture cannot explain the covariation between the two dis-
orders in clinical samples. Our results also show that
high levels of inattention and hyperactivity/impulsivity
are seen in both ASD and ADHD. This supports the
need for a dimensional framework that examines neuro-
developmental domains across traditional diagnostic
boundaries. Clinically, this emphasizes the importance of
careful screening for social communication difficulties
and RRBIs in children presenting with high levels of in-
attention and hyperactivity/impulsivity. Moreover, fe-
males had lower component scores across social-
communication, RRBI, and hyperactivity/impulsivity
than males, suggesting that there may be gender-related
phenotypes in the two neurodevelopmental conditions.
An increasing amount of literature suggests that females
show fewer observable difficulties than males, secondary
to their tendency to “camouflage” or compensate for dif-
ficulties. This highlights the need for careful screening of
ASD symptomatology in females, especially those with
ADHD.
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